Skip to main content

RLEA · Rubber Leaf Inc · Financials

Track RLEA — free
$4.50 At close · Apr 29
Market Cap
$184.99M
Shares
41.11M
Volume · Apr 29 120 Avg daily vol (5 sessions) 302

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$4.9M -29.2%
FY2025 Revenue FY2021–FY2025
Net Income
$2.87M +230.1%
FY2025 Net Income FY2021–FY2025
Gross Margin
16.22% +26.9pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
-38.28% -30.6pp
FY2025 Operating Margin FY2021–FY2025
Diluted EPS
$0.07 +240%
FY2025 Diluted EPS FY2022–FY2025
Operating Cash Flow
-$153.85K +69.7%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021
— $4.9M $6.93M $9.99M $10.65M $14.6M
$9.61M $4.11M $7.67M $10.35M $9.15M $15.78M
$1.34M $795.25K -$739.54K -$356K $1.5M -$1.18M
— 16.22% -10.67% -3.56% 14.07% -8.11%
— — $20.43K $86.75K $68.32K $217.26K
$116.82K $200.35K $535.93K $710.46K $917.41K $1.28M
— — $729.35K $599.44K $660.78K $601.34K
$2.59M $2.67M $535.93K $797.21K $985.73K $1.74M
-$1.57M -$1.88M -$535.93K -$1.15M $512.73K -$2.92M
— -38.28% -7.73% -11.54% 4.82% -20.03%
— — $193.42K -$553.77K $1.17M -$2.32M
-$192.62K -$6995 $356.44K $237.58K $187.53K $183.54K
$192.62K $6995 -$411.84K -$228.87K $255.68K -$244.98K
-$1.52M -$1.87M -$535.93K -$1.38M $768.41K -$3.17M
— $63.94K -$8609 $16.07K $11.03K —
$3.74M $2.87M -$2.2M -$1.4M $757.38K -$3.17M
— 58.47% -31.8% -14% 7.11% -21.71%
$3.65M $2.78M -$2.24M -$1.48M $768.97K -$3.02M
USD/shares $0.11 $0.07 -$0.05 -$0.03 $0.02 -$0.08
USD/shares $0.11 $0.07 -$0.05 -$0.03 $0.02 —
shares — 41.11M 41.11M 41.01M 40.98M 40.56M
shares — 41.11M 41.11M 41.01M 40.98M —
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current portion of other notes payable 2025-09-30 USD 251,297 10-Q filed 2025-11-19
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 1.12×
EV/EBIT
—
Peer median 23.12×
P/E (TTM)
—
Peer median 22.42×
Price/Sales (TTM)
—
Peer median 0.79×
Price/Book
393.03×
Peer median 1.27×

Peer medians compare against the 28 similar-size Specialty Chemicals companies (of 72 listed).

Valuation over time computed as of each quarter's filing date

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2024 FY2023 FY2022 FY2021
Corporate -$1,260,254 -$557,333 -$159,332 -$62,311
Key facts CIK 1893657 CUSIP 78109C109